BOSTON, June 27, 2023 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical…
FARMINGTON HILLS, Mich., June 27, 2023 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a…
FARMINGTON HILLS, Mich., June 27, 2023 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a…
WARRINGTON, Pa., June 27, 2023 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”)…
WARRINGTON, Pa., June 27, 2023 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”)…
TORONTO, June 27, 2023 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:…
TORONTO, June 27, 2023 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:…
All resolutions were approved. 35% of the issued shares represented. MADRID, Spain and BOSTON, June…
All resolutions were approved. 35% of the issued shares represented. MADRID, Spain and BOSTON, June…
VANCOUVER, British Columbia, June 27, 2023 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the…
Media Release SYDNEY, AUSTRALIA, June 27, 2023 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ:…
VANCOUVER, British Columbia, June 27, 2023 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the…
Media Release SYDNEY, AUSTRALIA, June 27, 2023 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ:…
Media Release SYDNEY, AUSTRALIA, June 27, 2023 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ:…
Media Release SYDNEY, AUSTRALIA, June 27, 2023 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ:…
Joint Venture (JV) combines CENTOGENE’s global leadership in multiomics with local insight of Lifera, a…
Joint Venture (JV) combines CENTOGENE’s global leadership in multiomics with local insight of Lifera, a…
SOUTH SAN FRANCISCO, Calif., June 27, 2023 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (Nasdaq: HARP),…
SOUTH SAN FRANCISCO, Calif., June 27, 2023 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (Nasdaq: HARP),…
Approval from FDA to initiate Phase II trial with LSALT peptide to target cardiac surgery-associated…